| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
|
Ann Neurol
|
2011
|
25.66
|
|
2
|
Consensus definitions proposed for pediatric multiple sclerosis and related disorders.
|
Neurology
|
2007
|
4.23
|
|
3
|
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.
|
Nat Med
|
2007
|
2.64
|
|
4
|
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions.
|
Mult Scler
|
2013
|
2.20
|
|
5
|
Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease.
|
Ann Neurol
|
2005
|
2.16
|
|
6
|
MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study.
|
Lancet Neurol
|
2011
|
2.12
|
|
7
|
Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy.
|
Ann Neurol
|
2010
|
1.81
|
|
8
|
Unusual variants of Alexander's disease.
|
Ann Neurol
|
2005
|
1.76
|
|
9
|
Treatment optimization in MS: Canadian MS Working Group updated recommendations.
|
Can J Neurol Sci
|
2013
|
1.74
|
|
10
|
The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.
|
Pediatrics
|
2006
|
1.50
|
|
11
|
Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis.
|
J Immunol
|
2009
|
1.50
|
|
12
|
Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination.
|
Neurology
|
2013
|
1.44
|
|
13
|
Hidden focal EEG seizures during prolonged suppressions and high-amplitude bursts in early infantile epileptic encephalopathy.
|
Clin Neurophysiol
|
2005
|
1.39
|
|
14
|
Epstein-Barr virus in pediatric multiple sclerosis.
|
JAMA
|
2004
|
1.38
|
|
15
|
Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis.
|
Ann Neurol
|
2012
|
1.32
|
|
16
|
International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials.
|
Arthritis Rheum
|
2007
|
1.28
|
|
17
|
Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases.
|
J Immunol
|
2013
|
1.27
|
|
18
|
2010 McDonald criteria for diagnosing pediatric multiple sclerosis.
|
Ann Neurol
|
2012
|
1.21
|
|
19
|
Lesion distribution in children with clinically isolated syndromes.
|
Ann Neurol
|
2008
|
1.17
|
|
20
|
Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis.
|
Curr Opin Neurol
|
2009
|
1.13
|
|
21
|
Guidelines on the use of intravenous immune globulin for neurologic conditions.
|
Transfus Med Rev
|
2007
|
1.08
|
|
22
|
Magnetic resonance imaging features of the spinal cord in pediatric multiple sclerosis: a preliminary study.
|
Neuroradiology
|
2010
|
1.07
|
|
23
|
Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy.
|
Neuron
|
2013
|
1.06
|
|
24
|
Pediatric multiple sclerosis.
|
Neurologist
|
2010
|
1.04
|
|
25
|
Update on biomarkers in neuromyelitis optica.
|
Neurol Neuroimmunol Neuroinflamm
|
2015
|
0.96
|
|
26
|
The management of multiple sclerosis in children: a European view.
|
Mult Scler
|
2010
|
0.95
|
|
27
|
Assessment of evidence for a protective role of vitamin D in multiple sclerosis.
|
Biochim Biophys Acta
|
2010
|
0.90
|
|
28
|
International Pediatric MS Study Group Clinical Trials Summit: meeting report.
|
Neurology
|
2013
|
0.89
|
|
29
|
Refractory primary central nervous system vasculitis of childhood: successful treatment with infliximab.
|
J Rheumatol
|
2012
|
0.87
|
|
30
|
Changes in cognitive performance over a 1-year period in children and adolescents with multiple sclerosis.
|
Neuropsychology
|
2013
|
0.87
|
|
31
|
Friedreich ataxia presenting as sudden cardiac death in childhood: clinical, genetic and pathological correlation, with implications for genetic testing and counselling.
|
Neuromuscul Disord
|
2010
|
0.87
|
|
32
|
Epstein-Barr virus in oral shedding of children with multiple sclerosis.
|
Neurology
|
2013
|
0.85
|
|
33
|
Editors' welcome and a working definition for a multiple sclerosis cure.
|
Mult Scler Relat Disord
|
2013
|
0.83
|
|
34
|
The demographic, clinical, and magnetic resonance imaging (MRI) features of transverse myelitis in children.
|
J Child Neurol
|
2011
|
0.83
|
|
35
|
Magnetic resonance imaging of a unique mutation in a family with Pelizaeus-Merzbacher disease.
|
Am J Med Genet A
|
2010
|
0.83
|
|
36
|
Pediatric multiple sclerosis.
|
J Child Neurol
|
2012
|
0.82
|
|
37
|
Masquerades of acquired demyelination in children: experiences of a national demyelinating disease program.
|
J Child Neurol
|
2012
|
0.82
|
|
38
|
Nocturnal hypoventilation: predictors and outcomes in childhood progressive neuromuscular disease.
|
Arch Dis Child
|
2010
|
0.82
|
|
39
|
The role of the cerebellum in multiple sclerosis.
|
Cerebellum
|
2015
|
0.81
|
|
40
|
Cerebral arterial and venous blood flow in adolescent multiple sclerosis patients and age-matched controls using phase contrast MRI.
|
J Magn Reson Imaging
|
2013
|
0.81
|
|
41
|
Diagnosing neuromyelitis optica.
|
Neuroimaging Clin N Am
|
2013
|
0.80
|
|
42
|
Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis.
|
Mult Scler
|
2013
|
0.80
|
|
43
|
Multiple sclerosis in children.
|
Semin Neurol
|
2008
|
0.80
|
|
44
|
Pediatric multiple sclerosis: pathobiological, clinical, and magnetic resonance imaging features.
|
Neuroimaging Clin N Am
|
2013
|
0.80
|
|
45
|
Subcutaneous interferon Beta-1a in pediatric multiple sclerosis: a retrospective study.
|
J Child Neurol
|
2013
|
0.79
|
|
46
|
Pharmacokinetics, safety and tolerability of miglustat in the treatment of pediatric patients with GM2 gangliosidosis.
|
Mol Genet Metab
|
2009
|
0.77
|
|
47
|
2010 McDonald criteria in a pediatric cohort: is positivity at onset associated with a more aggressive multiple sclerosis course?
|
Mult Scler
|
2013
|
0.77
|
|
48
|
Becker muscular dystrophy caused by an intronic mutation reducing the efficiency of the splice donor site of intron 26 of the dystrophin gene.
|
Neuromuscul Disord
|
2009
|
0.77
|
|
49
|
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials.
|
Neurology
|
2013
|
0.77
|
|
50
|
Treatment of pediatric multiple sclerosis.
|
Curr Treat Options Neurol
|
2015
|
0.77
|
|
51
|
Update on emerging therapies for multiple sclerosis.
|
Expert Rev Neurother
|
2010
|
0.77
|
|
52
|
Normalization of white matter intensity on T1-weighted images of patients with acquired central nervous system demyelination.
|
J Neuroimaging
|
2014
|
0.76
|
|
53
|
Coming of age: the use of immunomodulatory therapy in children with multiple sclerosis.
|
Neurology
|
2005
|
0.76
|
|
54
|
Mosaic microdeletion of 17p11.2-p12 and duplication of 17q22-q24 in a girl with Smith-Magenis phenotype and peripheral neuropathy.
|
Am J Med Genet A
|
2013
|
0.76
|
|
55
|
Lymphohistiocytosis in the brain: recognition of a potentially reversible aspect of primary HLH.
|
Neurology
|
2012
|
0.75
|
|
56
|
Complete deletion of the aprataxin gene: ataxia with oculomotor apraxia type 1 with severe phenotype and cognitive deficit.
|
BMJ Case Rep
|
2009
|
0.75
|
|
57
|
Mimics and rare presentations of pediatric demyelination.
|
Neuroimaging Clin N Am
|
2013
|
0.75
|
|
58
|
Editors' Welcome.
|
Mult Scler Relat Disord
|
2015
|
0.75
|
|
59
|
Solitary tumefactive demyelinating lesions in children.
|
J Child Neurol
|
2011
|
0.75
|
|
60
|
Editors' welcome.
|
Mult Scler Relat Disord
|
2012
|
0.75
|
|
61
|
Editors' Welcome.
|
Mult Scler Relat Disord
|
2015
|
0.75
|
|
62
|
Editors' welcome.
|
Mult Scler Relat Disord
|
2015
|
0.75
|
|
63
|
Editors׳ welcome.
|
Mult Scler Relat Disord
|
2014
|
0.75
|
|
64
|
Noninfectious central nervous system inflammatory disorders.
|
Semin Pediatr Neurol
|
2011
|
0.75
|
|
65
|
Multiple Sclerosis is a multifaceted disease.
|
Mult Scler Relat Disord
|
2014
|
0.75
|
|
66
|
Editors' welcome.
|
Mult Scler Relat Disord
|
2015
|
0.75
|
|
67
|
Editors' welcome.
|
Mult Scler Relat Disord
|
2014
|
0.75
|
|
68
|
Pediatric multiple sclerosis.
|
Curr Opin Neurol
|
2017
|
0.75
|
|
69
|
Editors׳ welcome.
|
Mult Scler Relat Disord
|
2015
|
0.75
|
|
70
|
Editors' Welcome.
|
Mult Scler Relat Disord
|
2015
|
0.75
|
|
71
|
Editor's Welcome.
|
Mult Scler Relat Disord
|
2011
|
0.75
|
|
72
|
Editors' welcome.
|
Mult Scler Relat Disord
|
2014
|
0.75
|
|
73
|
Editors' welcome.
|
Mult Scler Relat Disord
|
2012
|
0.75
|
|
74
|
Editors' Welcome.
|
Mult Scler Relat Disord
|
2016
|
0.75
|
|
75
|
Editors׳ welcome.
|
Mult Scler Relat Disord
|
2014
|
0.75
|
|
76
|
Pediatric Demyelination.
|
Continuum (Minneap Minn)
|
2016
|
0.75
|
|
77
|
Editors' Welcome.
|
Mult Scler Relat Disord
|
2016
|
0.75
|
|
78
|
Standardized magnetic resonance imaging acquisition and reporting in pediatric multiple sclerosis.
|
Neuroimaging Clin N Am
|
2013
|
0.75
|
|
79
|
Oral dosing requirements for phenytoin in the first three months of life.
|
J Popul Ther Clin Pharmacol
|
2010
|
0.75
|
|
80
|
Editors' Welcome.
|
Mult Scler Relat Disord
|
2016
|
0.75
|